WITHOUT RESEARCH BREAKTHROUGHS, MECP2 DUPLICATION SYNDROME WILL CONTINUE TO DEVASTATE THOSE AFFECTED AND THEIR FAMILIES.
CUREMDS is a subsidiary of the Rett Syndrome Research Trust
EIN: 26-0687439
WITHOUT RESEARCH BREAKTHROUGHS, MECP2 DUPLICATION SYNDROME WILL CONTINUE TO DEVASTATE THOSE AFFECTED AND THEIR FAMILIES.